Tom Hawes, M.D.

Managing Director

Tom is a Managing Director of the Blue Venture Fund.

He is the Board Chairman for Patientco. He serves as a Board Member of Octave Bioscience, Perspectum, Verata Health, UpwardHealth, and Oncology Analytics. He is a Board Observer of Healthify and Thrive. Previously on the board of InVivoLink (acquired by HCA), Nexidia (acquired by NICE), and AbleTo. Before joining the BVF, Tom matched at Yale School of Medicine for residency and completed his first year of medical training at Greenwich Hospital.

During his medical training, he worked on clinical studies at the ISK Institute for Orthopaedics and Sports Medicine and on outcomes research at the National Cancer Institute and NYMC’s Cardiothoracic Surgery Department. Tom is on the National Advisory Board of the Desmoid Tumor Research Foundation. Tom holds a BA from Brigham Young University, an M.D. from New York Medical College and an MBA from Harvard Business School. He is also a Kauffman Fellow.